Can elevated liver enzymes cause a denial?

Written by Hannah McCullough Insurance Researcher & Writer

An elevated ALT or AST result is a finding, not a diagnosis. It can reflect liver injury, but AST can also rise for reasons outside the liver. That distinction matters in underwriting because the same lab result can point to very different health questions. Do not assume a single abnormal panel predicts the application result.

What does an elevated liver enzyme result mean for life insurance?

An elevated liver enzyme result tells an insurer that the application may need more medical context. It does not, by itself, establish the cause or severity of a liver condition. The American Association for the Study of Liver Diseases explains that ALT and AST are markers of liver injury, while AST can also come from other tissues.

AASLD also cautions that the size of an aminotransferase elevation does not directly measure the extent of liver injury. Its explanation of elevated liver enzymes is useful context for reading a lab report.

That is why an underwriter may look beyond the flagged value. Relevant context can include the date of the test, the laboratory’s reference range, repeat results, symptoms, diagnoses, medications and supplements, alcohol history, imaging, and a clinician’s assessment. The exact questions and evidence requested depend on the application and the insurer. A consumer cannot turn an isolated ALT or AST value into a reliable approval prediction.

Which causes can lead to a closer review?

The cause of an abnormal result determines what needs to be clarified. MedlinePlus lists hepatitis, cirrhosis, mononucleosis, some medicines, alcohol use, muscle injury, and other conditions among possible reasons for a high AST. It also notes that results outside a reference range do not always mean a condition requires treatment, and that reference ranges can differ by laboratory. MedlinePlus’s AST test guidance explains why the result should be interpreted with other information.

A recent illness, a medication change, strenuous exercise, or an isolated laboratory variation may prompt a request for clarification rather than settle the application. A diagnosed chronic condition, repeated abnormalities, symptoms, or additional abnormal tests can require a more detailed review. Those are possibilities, not a universal underwriting rule. Only the insurer reviewing the actual record can decide how the finding affects eligibility and price.

How do life insurers review the rest of the application?

Life underwriting uses the information collected during the application process to classify risk and determine a rate. The National Association of Insurance Commissioners says traditional underwriting can include medical information such as a physical exam, blood, urine, and saliva testing. Some accelerated processes use outside data and may avoid an exam, but an insurer can still require more information when the application calls for it. The NAIC overview of accelerated underwriting describes both the medical information involved and the difference in possible processing time.

For an applicant with elevated enzymes, the useful record is usually the one that explains the result clearly. Depending on the case, that may include the original report, repeat labs, a problem-list diagnosis, imaging, specialist notes, treatment information, and the clinician’s current assessment. The goal is not to present a more favorable story. It is to answer the health questions completely and make the record easier to evaluate.

Can waiting or getting more records change the application?

Sometimes a complete follow-up record can answer questions that an isolated lab report cannot. Whether waiting is sensible depends on the medical issue and the reason for applying. A doctor can tell you whether repeat testing or evaluation is appropriate. An agent can explain what an insurer may ask for, but neither an agent nor a website can promise that a delay will produce a better offer.

If you apply while evaluation is still underway, answer the application accurately and disclose requested information. Omitting a known diagnosis or test can create a more serious problem than an abnormal result itself. If a carrier asks for an attending physician statement or additional records, provide the requested material through the proper process rather than guessing at what the underwriter needs.

If your medical history includes a transplant, the guide to life insurance options after successful liver transplant explains why the timing and records can require a separate review. The same principle applies here: an agent can discuss the process, but only the insurer can evaluate the complete medical file.

What if an application is postponed or declined?

Ask for the insurer’s stated reason and whether it needs additional records, a later date, or a new application. A postponement is not the same decision as a permanent denial, and a decline from one insurer does not establish what every insurer will do. Underwriting rules differ, so an independent licensed life insurance agent may help you understand the next step without promising a particular result.

Keep copies of the reports you submit and write down the dates of tests, diagnoses, and follow-up visits. If the record contains an error, ask the medical provider to correct it through the provider’s normal process. Use the corrected record when appropriate. Never alter a lab report or leave out a requested health detail to make an application look cleaner.

What should you do before applying?

Start with the medical question, not an assumed insurance outcome. Ask your clinician what the abnormal result means, what follow-up is recommended, and which records explain the current status. Then review the application questions carefully and prepare accurate dates, diagnoses, treatments, medications, and provider details. This preparation can make the review more orderly, although it cannot guarantee approval or a preferred rate.

Once you understand the record, you can see your estimated rate in minutes through the Quotecrusader process and decide whether to continue. An estimate is not a policy offer, and the insurer’s underwriting decision can differ after the full application and medical review.

What is the practical answer?

Elevated liver enzymes can contribute to a denial, but the lab flag is only one part of the decision. The underlying cause, persistence, related findings, and documented follow-up are more useful than a generic cutoff. Treat the result as a prompt to get accurate medical context, disclose it honestly, and ask a licensed life insurance agent what documentation may help the insurer review the case.

If you are ready to explore the next step, you can see your estimated rate in minutes after gathering the relevant health information. The result is an estimate, not a promise of approval, and a licensed life insurance agent can explain what happens if the insurer requests more records.